Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Berger

Showing results (821-830 of 1,161) with videos related to

Pageof 117
Sort By:
Annals of Surgical Oncology|March 30, 2016
KRAS and Combined KRAS/TP53 Mutations in Locally Advanced Rectal Cancer are Independently Associated with Decreased Response to Neoadjuvant TherapyOliver S Chow, Deborah Kuk, Metin Keskin, et al.
JCO Precision Oncology|January 29, 2019
Real-Time Genomic Characterization of Metastatic Pancreatic Neuroendocrine Tumors Has Prognostic Implications and Identifies Potential Germline ActionabilityNitya Raj, Ronak Shah, Zsofia Stadler, et al.
International Journal of Cardiology|July 5, 2011
Prolonged beneficial effect of bosentan treatment and 4-year survival rates in adult patients with pulmonary arterial hypertension associated with congenital heart diseaseJeroen C Vis, Marielle G Duffels, Pepijn Mulder, et al.
The Journal of Molecular Diagnostics : JMD|December 29, 2016
Next-Generation Assessment of Human Epidermal Growth Factor Receptor 2 (ERBB2) Amplification Status: Clinical Validation in the Context of a Hybrid Capture-Based, Comprehensive Solid Tumor Genomic Profiling AssayDara S Ross, Ahmet Zehir, Donavan T Cheng, et al.
Annals of the American Thoracic Society|June 28, 2021
Parenteral Prostanoids in Pediatric Pulmonary Arterial Hypertension: Start Early, Dose High, CombineJohannes M Douwes, Willemijn M H Zijlstra, Erika B Rosenzweig, et al.
British Journal of Clinical Pharmacology|December 17, 2009
Pharmacokinetic and clinical profile of a novel formulation of bosentan in children with pulmonary arterial hypertension: the FUTURE-1 studyMaurice Beghetti, Sheila G Haworth, Damien Bonnet, et al.
Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir|February 21, 2015
[Pediatric pulmonary hypertension]D Dunbar Ivy, Steven H Abman, Robyn J Barst, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|December 2, 2009
Bosentan in pulmonary arterial hypertension: a comparison between congenital heart disease and chronic pulmonary embolismM G J Duffels, M N van der Plas, S Surie, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 11, 2016
The oncocytic subtype is genetically distinct from other pancreatic intraductal papillary mucinous neoplasm subtypesOlca Basturk, Marcus Tan, Umesh Bhanot, et al.
Molecular Cancer Research : MCR|February 11, 2017
Chromosome 20q Amplification Defines a Subtype of Microsatellite Stable, Left-Sided Colon Cancers with Wild-type RAS/RAF and Better Overall SurvivalRyan N Ptashkin, Carlos Pagan, Rona Yaeger, et al.
Pageof 117

Showing results (821-830 of 1,161) with videos related to

Sort By:
Pageof 117
Annals of Surgical Oncology|March 30, 2016
KRAS and Combined KRAS/TP53 Mutations in Locally Advanced Rectal Cancer are Independently Associated with Decreased Response to Neoadjuvant TherapyOliver S Chow, Deborah Kuk, Metin Keskin, et al.
JCO Precision Oncology|January 29, 2019
Real-Time Genomic Characterization of Metastatic Pancreatic Neuroendocrine Tumors Has Prognostic Implications and Identifies Potential Germline ActionabilityNitya Raj, Ronak Shah, Zsofia Stadler, et al.
International Journal of Cardiology|July 5, 2011
Prolonged beneficial effect of bosentan treatment and 4-year survival rates in adult patients with pulmonary arterial hypertension associated with congenital heart diseaseJeroen C Vis, Marielle G Duffels, Pepijn Mulder, et al.
The Journal of Molecular Diagnostics : JMD|December 29, 2016
Next-Generation Assessment of Human Epidermal Growth Factor Receptor 2 (ERBB2) Amplification Status: Clinical Validation in the Context of a Hybrid Capture-Based, Comprehensive Solid Tumor Genomic Profiling AssayDara S Ross, Ahmet Zehir, Donavan T Cheng, et al.
Annals of the American Thoracic Society|June 28, 2021
Parenteral Prostanoids in Pediatric Pulmonary Arterial Hypertension: Start Early, Dose High, CombineJohannes M Douwes, Willemijn M H Zijlstra, Erika B Rosenzweig, et al.
British Journal of Clinical Pharmacology|December 17, 2009
Pharmacokinetic and clinical profile of a novel formulation of bosentan in children with pulmonary arterial hypertension: the FUTURE-1 studyMaurice Beghetti, Sheila G Haworth, Damien Bonnet, et al.
Turk Kardiyoloji Dernegi Arsivi : Turk Kardiyoloji Derneginin Yayin Organidir|February 21, 2015
[Pediatric pulmonary hypertension]D Dunbar Ivy, Steven H Abman, Robyn J Barst, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|December 2, 2009
Bosentan in pulmonary arterial hypertension: a comparison between congenital heart disease and chronic pulmonary embolismM G J Duffels, M N van der Plas, S Surie, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 11, 2016
The oncocytic subtype is genetically distinct from other pancreatic intraductal papillary mucinous neoplasm subtypesOlca Basturk, Marcus Tan, Umesh Bhanot, et al.
Molecular Cancer Research : MCR|February 11, 2017
Chromosome 20q Amplification Defines a Subtype of Microsatellite Stable, Left-Sided Colon Cancers with Wild-type RAS/RAF and Better Overall SurvivalRyan N Ptashkin, Carlos Pagan, Rona Yaeger, et al.
Pageof 117